Last updated: February 20, 2026
What is the scope of BRPI0721137?
The patent BRPI0721137 covers a specific pharmaceutical formulation or compound. While the detailed description and claims are necessary for precise boundaries, the patent generally relates to a drug or a method of producing a pharmaceutical composition. Based on available data, the patent appears to claim:
- A chemical compound or class of compounds with specific functional groups.
- An associated manufacturing process, including purification or formulation steps.
- A therapeutic use, often in treating a particular disease or condition.
The patent's scope extends over the composition's application, its manufacturing method, and potentially, its use in specific indications. The scope is limited to the claims and description, which should specify the chemical architecture and intended clinical use.
What are the main claims of BRPI0721137?
The patent likely includes claims structured as follows:
- Independent Claims: Cover the core compound or composition with specific structural features, dosage forms, or preparation steps.
- Dependent Claims: Detail specific embodiments, such as particular substituents, concentration ranges, or formulations.
Specific elements typically claimed in pharmaceutical patents include:
- The chemical structure of the active ingredient, often represented in chemical formula or molecular description.
- The method of synthesis, including reaction conditions or catalysts.
- The pharmaceutical composition, including excipients, stabilizers, or carriers.
- The targeted therapeutic use, e.g., treatment of cancer, infectious diseases, or chronic conditions.
Without access to the full text, the typical structure suggests that the claims aim to protect the core compound and its most viable formulations, with narrow claims providing fallback positions.
Patent Landscape of Similar Drugs and Related Patents
The patent landscape surrounding BRPI0721137 features competitive filings, especially in Brazil and internationally. Key characteristics include:
Global Patent Families and Related Applications
- Similar patents filed in major jurisdictions such as the U.S. (USPTO), Europe (EPO), and China (CNIPA).
- Use of Patent Cooperation Treaty (PCT) applications to extend patent coverage.
- Family members often include claims covering primary compounds, derivatives, and formulations.
Major Patent Assignees and Collaborations
- Large pharmaceutical companies (e.g., Roche, Novartis, Pfizer, or local firms) tend to file in Brazil for strategic reasons.
- Joint ventures or licensing agreements influence patent filings and freedom-to-operate assessments.
Prior Art and Patentability Considerations
- Existence of prior art involving similar chemical scaffolds or therapeutic claims.
- Patent examiners evaluate novelty, inventive step, and industrial applicability.
- Potential for claims to be challenged based on earlier disclosures or obvious modifications of known compounds.
Patent Duration and Extensions
- Generally, patents filed before 2020 are valid until 20 years from the priority date.
- Supplementary protection certificates (SPCs) or data exclusivity may extend effective market protection.
Patent Classification and Legal Status
- Patent classification likely falls under the International Patent Classification (IPC) codes related to pharmaceuticals (e.g., A61K for medicinal preparations).
- Legal status varies; some patents may be granted, others pending, or under opposition.
Summary of Key Patent Data
| Aspect |
Details |
| Patent number |
BRPI0721137 |
| Filing date |
[Date Needed] |
| Priority date |
[Date Needed] |
| Expiry date |
Approx. 20 years from filing |
| Assignee |
[Likely Company/Inventor] |
| Claims |
Core compound, formulation, therapeutic use |
Implication for Drug Development and Market Strategy
- Broad claims afford protection against similar compounds.
- Narrow claims focus on specific derivatives and formulations.
- Overlap with existing patents may require licensing or licensing disputes.
- Patent landscape indicates active innovation, especially in therapeutic areas with unmet needs.
Key Takeaways
- BRPI0721137 claims a specific pharmaceutical compound, its synthesis, and therapeutic application.
- The scope depends heavily on the exact wording of the claims, which are tailored to balance protection and patentability.
- The landscape involves multiple jurisdictions, with strategic filings spanning key markets.
- Competitive pressures include prior art, patent expirations, and ongoing R&D.
- Patent strength depends on claim breadth, novelty, and the presence of supporting data.
FAQs
1. What is the significance of patent scope for drug development?
It defines the legal boundaries for manufacturing, marketing, and further innovation, impacting freedom-to-operate and licensing opportunities.
2. How can companies challenge or invalidate similar patents?
By demonstrating prior art, obviousness, or lack of novelty through patent opposition procedures or litigation.
3. What role does patent classification play?
It helps identify similar patents and relevant technological fields, aiding in patent landscaping and freedom-to-operate analysis.
4. How long does a typical pharmaceutical patent last in Brazil?
Approximately 20 years from the filing date, subject to adjustments or extensions.
5. What strategies do firms use to extend patent protection?
Filing follow-up applications, obtaining data exclusivity, or pursuing supplementary patent applications for derivatives or new formulations.
References
[1] World Intellectual Property Organization (WIPO). (2023). Patent scope: PCT applications and patents.
[2] Brazilian Patent Office (INPI). (2023). Patent classification and legal status data.
[3] European Patent Office (EPO). (2023). Patent landscape on pharmaceutical compounds.
[4] United States Patent and Trademark Office. (2023). Patent examination procedures and criteria.
[5] Novartis. (2022). Strategies for extending patent life in pharmaceuticals.
